{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31585899", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "01"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "2768-6698", "JournalIssue": {"Volume": "25", "Issue": "3", "PubDate": {"Year": "2020", "Month": "Jan", "Day": "01"}}, "Title": "Frontiers in bioscience (Landmark edition)", "ISOAbbreviation": "Front Biosci (Landmark Ed)"}, "ArticleTitle": "T-96 attenuates inflammation by inhibiting NF-\u03baB in adjuvant-induced arthritis.", "Pagination": {"StartPage": "498", "EndPage": "512", "MedlinePgn": "498-512"}, "Abstract": {"AbstractText": ["The extract of the medicinal plant, <i>Tripterygium wilfordii</i> Hook. f. (TW), has been used in the treatment of diverse autoimmune diseases, including rheumatoid arthritis. However, the high frequency of toxic side effects has limited its clinical use. In order to reduce toxicity without losing the therapeutic benefit, the pharmacological activity and toxicity of four compounds (T-96, triptolide, neotripterifordin, and tripterifordin) from TW were evaluated. The current study revealed that these compounds interfere with the IL-1\u03b2 signaling pathway, which stimulates the secretion of pro-inflammatory cytokines (IL-6) in primary rheumatoid arthritis synovial fibroblasts (RASFs). These compounds inhibit IL-6 production, and among these, T-96 was the most effective. Moreover, T-96 blocks activation of NF-kappa B and p38 and ameliorates the joint destruction and the clinical signs of the disease in adjuvant-induced arthritic rats. These data suggest that among the four compounds of the TW, T-96 possesses highest anti-rheumatoid arthritis activity though inhibiting IL-1-mediated inflammatory signaling pathways."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University; No.639 Longmian Avenue, Nanjing, 211198, P.R.China."}], "LastName": "Yu", "ForeName": "Yun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory Animal Center of Nanjing University of Chinese Medicine, Nanjing 210023, China."}], "LastName": "Yong", "ForeName": "Bian", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory Animal Center of Nanjing University of Chinese Medicine, Nanjing 210023, China."}], "LastName": "Xu", "ForeName": "Changliang", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University; No.639 Longmian Avenue, Nanjing, 211198, P.R.China, cl.xu81@gmail.com."}], "LastName": "Zhang", "ForeName": "Luyong", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Singapore", "MedlineTA": "Front Biosci (Landmark Ed)", "NlmUniqueID": "101612996", "ISSNLinking": "2768-6698"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "demethylzeylasteral"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["metabolism", "prevention & control"], "DescriptorName": "Arthritis, Experimental"}, {"QualifierName": ["metabolism", "prevention & control"], "DescriptorName": "Arthritis, Rheumatoid"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["blood", "metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Fibroblasts"}, {"QualifierName": ["metabolism", "prevention & control"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Synovial Membrane"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tripterygium"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Triterpenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "16", "Hour": "6", "Minute": "0"}], "PublicationStatus": "epublish", "ArticleIdList": ["31585899", "10.2741/4816", "4816"]}}]}